Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer

Author:

Nama Vivek1,Angelopoulos Georgios2,Twigg Jeremy3,Murdoch John B4,Bailey Jo4,Lawrie Theresa A5

Affiliation:

1. Croydon University Hospital; Gynaecological Oncology; London Road Croydon UK CR7 7YE

2. The James Cook University Hospital; Gynaecological Oncology; Marton Road Middlesbrough UK TS4 3BW

3. South Tees NHS Foundation Trust; Marton Road Middlesbrough UK TS4 3BW

4. St Michael's Hospital; Department of Gynaecological Oncology; Southwell Street Bristol UK BS2 8EG

5. 1st Floor Education Centre, Royal United Hospital; Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group; Combe Park Bath UK BA1 3NG

Publisher

Wiley

Subject

Pharmacology (medical)

Reference51 articles.

1. Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer;Park;Journal of Gynecologic Oncology,July 2012

2. A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality;Alleyne-Mike;International Journal of Gynecological Cancer,2013

3. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy;Atlan;International Journal of Radiation Oncology, Biology, Physics,2002

4. Bayo J Bermudez A Castro NE Neoadjuvant chemotherapy (NC) plus radical hysterectomy (RH) vs. concurrent chemoradiation (CC) in locally advanced cervical carcinoma: a preliminary report of feasibility and complications [abstract] International Journal of Gynecological Cancer, special online supplement: www.blackwellscience.com/ijg. VIII meeting of the International Gynecologic Cancer Society Buenos Aires, Argentina 2000 Abstract 64

5. Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy;Bloss;Gynecologic Oncology,1992

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3